
Conference Coverage
Latest Content

Psychedelic PSX-001 for Generalized Anxiety Disorder: A Conversation With Lou Barbato, MD

Catatonia Crisis: Navigating the IV Lorazepam Shortage

Quantifying Generative AI Use for Mental Health Advice Among Adolescents

Data Presentation on XPro1595 for Alzheimer Disease With Inflammation at CTAD

The Concept of Mental Illness, and Why the DSM Approach Is Wrong

Shorts










Digital Edition
Podcasts
All News

Bristol Myers Squibb expands patient enrollment in the ADEPT-2 study, exploring Cobenfy's potential for treating Alzheimer disease-related psychosis.

Explore impactful ways to contribute on Giving Tuesday, supporting mental health organizations dedicated to making a difference in psychiatry.

Meta-analysis identifies 2 antidepressants that separate from placebo and other antidepressants in relieving negative symptoms of schizophrenia

Adolescent cannabis use surges in Oklahoma, raising public health concerns amid rising THC potency and permissive regulations.

Discover the positive shifts in psychiatry, from youth mental health improvements to innovative treatment technologies, amidst current challenges.

What are the most important psychiatric advancements and insights from 2025? Share with us!

Read discussion of bromism, with case studies and background on bromine.

ChatGPT's rapid rise sparks debate on its profound impact, blending remarkable capabilities with alarming risks, as society grapples with AI's future.

Explore the importance of gratitude in psychiatry, addressing challenges, stigma, and the pursuit of mental health improvement in communities.

Explore updates from November 2025, including AI, drug updates, and more.

"When the spade sinks into gravelly ground: My father, digging. I look down..."

Tiffani Bell-Washington, MD, MPH shares insights on compassionate lifestyle changes for adolescents facing obesity, emphasizing collaboration and individualized care strategies.

In this CME article, explore effective strategies for assessing and preventing suicide risk in patients with bipolar disorder, including interdisciplinary approaches and evidence-based interventions.

Lithium significantly reduces suicidal ideation and attempts in bipolar and major depressive disorder patients, enhancing long-term treatment outcomes.













































